Moxifloxacin: a review of the microbiological, pharmacological, clinical and safety features.

Expert Opin Pharmacother

Department of Clinical Microbiology, Royal University Hospital and the University of Saskatchewan, 103 Hospital Drive, Saskatoon, Saskatchewan S7N 0W8, Canada.

Published: February 2001

AI Article Synopsis

Article Abstract

Antimicrobial agents are used to treat patients with infectious diseases. Initial antimicrobial compounds originated from natural sources and were generally deemed to be narrow in spectrum. Today, we are in the era of designer drugs that have been specifically developed with current issues in infectious diseases in mind. For example, some new compounds require once daily dosing, have minimal side effects, are active against resistant pathogens and, for some, have a lower propensity for selecting for antimicrobial resistance during patient therapy.

Download full-text PDF

Source
http://dx.doi.org/10.1517/14656566.2.2.317DOI Listing

Publication Analysis

Top Keywords

infectious diseases
8
moxifloxacin review
4
review microbiological
4
microbiological pharmacological
4
pharmacological clinical
4
clinical safety
4
safety features
4
features antimicrobial
4
antimicrobial agents
4
agents treat
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!